ÂÜÀòÂÒÂ×

Annu Batra is a seasoned professional with extensive experience in strategy development and execution across various sectors, particularly in healthcare. Currently serving as Senior Director and Pipeline Lead for Emerging Therapies at Novo Nordisk since August 2021, Annu previously held the position of Senior Manager in Strategy & Business Consulting at Bayer. Annu's earlier roles include Strategy Engagement Manager at Monitor Deloitte, where guidance was provided to C-Suite executives, as well as key positions at Merck. Annu holds an MBA from The Tuck School of Business at Dartmouth and a Bachelor's degree in Finance and Economics from NYU Stern School of Business. Areas of expertise include corporate strategy, business transformation, executive communication, and team management.